2025 HCPCS Code Q0243
Injection, casirivimab and imdevimab, 2400 mg
TAGS: casirivimab| Short Description | Casirivimab and imdevimab |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | November 21, 2020 |
| HCPCS Action Effective Date | November 21, 2020 |
| HCPCS Pricing Indicator Code | 54 - Vaccinations |
| HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q5123 - Inj. riabni, 10 mg
- Q5124 - Inj. byooviz, 0.1 mg
- Q5125 - Inj, releuko 1 mcg
- Q5126 - Inj alymsys 10 mg
- Q5127 - Inj, stimufend, 0.5 mg
- Q5128 - Inj, cimerli, 0.1 mg
- Q5129 - Inj, vegzelma, 10 mg
- Q5130 - Inj, fylnetra, 0.5 mg
- Q5131 - Inj, idacio, 20 mg
- Q5132 - Inj, abrilada, 10 mg
- Q5133 - Inj, tofidence, 1 mg
- Q5134 - Inj, tyruko, 1 mg
- Q5137 - Inj, wezlana, sub cu, 1 mg
- Q5138 - Inj, wezlana, iv, 1 mg
- Q9001 - Chaplain assessment
- Q9002 - Chaplain counsel individu
- Q9003 - Chaplain counsel group
- Q9004 - Va whole health partner serv
- Q9950 - Inj sulf hexa lipid microsph
- Q9951 - Locm >= 400 mg/ml iodine,1ml